Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines Calavo Growers Q1 2026 Earnings EPS Beats Estimates by 23 Amid Operational Improvements UTMD Q1 2024 Earnings EPS of 109 Highlights Operational Stability Amid Quiet Quarter OPXS Q1 2026 Earnings EPS of 003 Reflects Profitability Revenue Details Not Disclosed INGR Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Stock Holds Steady Saratoga Investment Corp 600 Notes due 2027 SAT Q1 2026 Earnings Significant Miss as EPS Falls to 016